Full preclinical validation of the 123I-labeled anti-PSMA antibody fragment ScFvD2B for prostate cancer imaging
Abstract
// Barbara Frigerio 1 , Gerben Franssen 5 , Elena Luison 1 , Alessandro Satta 1 , Ettore Seregni 2 , Marco Colombatti 3 , Giulio Fracasso 3 , Riccardo Valdagni 4 , Delia Mezzanzanica 1 , Otto Boerman 5 , Silvana Canevari 1,* and Mariangela Figini 1,* 1 Department of Experimental Oncology and Molecular Medicine, S.S. Molecular Therapies, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy 2 S.C. Nuclear Medicine, Fondazione IRCCS...
Paper Details
Title
Full preclinical validation of the 123I-labeled anti-PSMA antibody fragment ScFvD2B for prostate cancer imaging
Published Date
Dec 30, 2016
Journal
Volume
8
Issue
7
Pages
10919 - 10930
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History